IRVINE, Calif.--(BUSINESS WIRE)--Pegasus Biologics, Inc., developers of advanced biologic scaffolds, announced today that they have received FDA clearance for the DermADAPT™ Biomatrix Wound Dressing, a highly organized collagen matrix intended for the local management of moderate to heavy exuding wounds. The Company will initially focus on the enormous opportunity within the diabetic foot ulcer market.
